These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
111 related items for PubMed ID: 5516187
41. [Value of various immunological tests in clinical aspects of pulmonary tuberculosis]. Savula MM. Probl Tuberk; 1978 May; (5):22-5. PubMed ID: 353799 [No Abstract] [Full Text] [Related]
42. [Structure of the organs of immunity in local experimental pulmonary tuberculosis in rabbits]. Averbakh MM, Poberiĭ IA, Ul'ianov MI, Lindner DP. Probl Tuberk; 1979 Aug; (8):52-6. PubMed ID: 482270 [No Abstract] [Full Text] [Related]
43. [Cavity formation and cellular immunity]. Maeda H, Yamamura Y, Ogawa A, Tomiya I, Tahara T. Kekkaku; 1980 Oct; 55(10):461-5. PubMed ID: 6785510 [No Abstract] [Full Text] [Related]
44. [The functional activity of class-I and -II HLA antigens in pulmonary tuberculosis]. Selitskaia RP, Ponomareva IuIu. Probl Tuberk; 1996 Oct; (1):47-9. PubMed ID: 8907488 [Abstract] [Full Text] [Related]
45. [Immunostimulating and tissue therapy in the combined treatment of patients with pulmonary tuberculosis]. Voĭtova DI, Kozlova NV, Korelin VK, Tress AS. Probl Tuberk; 1983 Sep; (9):46-9. PubMed ID: 6647445 [No Abstract] [Full Text] [Related]
46. [Immunologic methods and their use for diagnosis in the treatment of pulmonary tuberculosis]. Knoring BE. Probl Tuberk; 1994 Sep; (4):25-7. PubMed ID: 7984609 [Abstract] [Full Text] [Related]
47. [Cellular immunity in allergic diseases]. Kupchinskas IuK, Shmigel'skene NI. Klin Med (Mosk); 1971 Mar; 49(3):23-6. PubMed ID: 5562411 [No Abstract] [Full Text] [Related]
48. [Effect of rifampicin on cell mediated immunity in patients with pulmonary tuberculosis--with special reference to interferon-producing ability of peripheral blood lymphocytes]. Hirano A. Kekkaku; 1984 Jun; 59(6):385-93. PubMed ID: 6492549 [No Abstract] [Full Text] [Related]
49. [Immune status characteristics as the basis for the prognosis of lung diseases]. Knoring BE. Probl Tuberk; 1996 Jun; (1):15-7. PubMed ID: 8907475 [Abstract] [Full Text] [Related]
53. Impaired antigen-specific CD4(+) T lymphocyte responses in cavitary tuberculosis. Barry S, Breen R, Lipman M, Johnson M, Janossy G. Tuberculosis (Edinb); 2009 Jan; 89(1):48-53. PubMed ID: 18799355 [Abstract] [Full Text] [Related]
54. [Forms of the specific immune response in tuberculosis and their relationship to the morphological characteristics of the process]. Knoring BE, Chuzhova NM, Otten TF, Raskina ES. Probl Tuberk; 1980 Apr; (4):47-51. PubMed ID: 6770366 [No Abstract] [Full Text] [Related]
55. [Experimental study on prevention of tuberculous cavity formation]. Ogawa Y. Iryo; 1969 Nov; 23(11):1357-63. PubMed ID: 5370256 [No Abstract] [Full Text] [Related]
56. [Significance of immunologic testing of patients in surgery of pulmonary tuberculosis]. Repin IuM, El'kin AV, Knoring BE, Trofimov MA. Probl Tuberk; 1996 Nov; (2):20-1. PubMed ID: 8657687 [Abstract] [Full Text] [Related]